How immune cells are activated Research PSI A research consortium has deciphered the mechanism of CCR5 receptor activation, providing insights for the development of CCR5 drug antagonists for AIDS, cancer, and inflammatory diseases. They build proteins that are not known to nature TechTransfer ETH Zurich Using chemical synthesis, Bright Peak Therapeutics can produce proteins that have never before existed. This holds great potential for cancer immunotherapy. The Basel-based spin-off has its beginnings at ETH Zurich. Assistent professor Klaus Eyer on the topic of vaccinations Research ETH Zurich In the video series "Ask the Expert", experts from ETH Zurich answer questions from the community. In this episode Klaus Eyer talks about vaccinations. Better choice of contraceptives can prevent breast cancer Research EPFL There is a strong link between hormonal contraceptives and breast cancer risk. The main culprit are progestins, synthetic mimics of the pregnancy hormone progesterone that stimulate cell growth in the breast. An EPFL study into the distinct biological effects of different progestins on the breast shows that contraceptive-related breast cancer can be prevented by more informed choices about the composition of contraceptives. Luring bacteria into a trap Research ETH Zurich Researchers at ETH Zurich and the University of Basel have developed a vaccine that protects animals from Salmonella. These bacteria often escape the effects of vaccination by genetically modifying their protective coat. The researchers have succeeded in manipulating this process to lure the bacteria into an evolutionary trap. The simulated patient Research Empa Digital twins enable customized medical therapies. Empa researchers have now modeled several hundred such avatars based on real people and treated them experimentally. For the first time, the digital twins received feedback from real patients. Previous 30 31 32 33 34 35 36 37 Next Page 34 of 37
